Therapeutic effects of reduced glutathione on liver function, fibrosis, and HBV DNA clearance in chronic hepatitis B patients
Abstract Objective To evaluate the therapeutic impact of reduced glutathione combined with entecavir on liver function, fibrosis, and HBV-DNA clearance in chronic hepatitis B patients. Methods This was a randomized controlled trial. This study included 90 patients diagnosed with chronic hepatitis B,...
Saved in:
Main Authors: | Qiyao Wei, Jing Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-02-01
|
Series: | BMC Gastroenterology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12876-025-03600-z |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of hepatitis B vaccination in patients awaiting liver transplantation in prophylaxis of <i>de novo</i> HBV-infection of a graft
by: V. Ye. Syutkin, et al.
Published: (2010-04-01) -
Chronic hepatitis C course at elderly and therapeutic approach
by: M. V. Mayevskaya, et al.
Published: (2011-02-01) -
Antiviral therapy and regression of liver fibrosis at chronic hepatitis B
by: D. T. Abdurakhmanov
Published: (2010-02-01) -
Long-Term Monitoring of Liver Fibrosis and Steatosis in Patients with Chronic Hepatitis C after Achieving a Sustained Virologic Response to Antiviral Therapy
by: K. R. Dudina, et al.
Published: (2023-02-01) -
Quantitative ultrasound rating of liver fibrosis in children with cystic fibrosis
by: G. M. Dvoryakovskaya, et al.
Published: (2014-08-01)